Royce & Associates’s Standard BioTools LAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.76M Buy
3,005,529
+120,000
+4% +$145K 0.03% 545
2025
Q4
$3.69M Buy
2,885,529
+80,810
+3% +$109K 0.04% 513
2025
Q3
$3.65M Buy
2,804,719
+167,598
+6% +$220K 0.04% 517
2025
Q2
$3.16M Buy
2,637,121
+636,618
+32% +$706K 0.03% 541
2025
Q1
$2.16M Buy
2,000,503
+545,000
+37% +$765K 0.02% 579
2024
Q4
$2.55M Buy
1,455,503
+840,951
+137% +$1.57M 0.02% 595
2024
Q3
$1.19M Buy
614,552
+310,321
+102% +$608K 0.01% 708
2024
Q2
$538K Buy
+304,231
New +$744K 0.01% 785
2019
Q4
Sell
-122,400
Closed -$567K 1157
2019
Q3
$567K Sell
122,400
-63,000
-34% -$496K 0.01% 881
2019
Q2
$2.28M Hold
185,400
0.02% 695
2019
Q1
$2.46M Buy
185,400
+37,000
+25% +$390K 0.02% 681
2018
Q4
$1.28M Buy
+148,400
New +$1.16M 0.01% 824
2013
Q4
Sell
-3,300
Closed -$72K 1458
2013
Q3
$72K Hold
3,300
﹤0.01% 1378
2013
Q2
$58K Buy
+3,300
New +$57.9K ﹤0.01% 1368

Other funds holding LAB